| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |